Master of Pharmaceutical Regulatory Affairs
In the interests of bridging international pharmaceutical development and approval The Faculty of Pharmaceutical Sciences in cooperation with The Danish Association of the Pharmaceutical Industry/Medicademy offers a master’s programme in Pharmaceutical Regulatory Affairs.
The aim of the master’s programme is to provide participants with solid theoretical and practical up to date knowledge in international regulatory affairs related to pharmaceutical, biological and biotech product development.
The master’s programme is designed for professionals who are employed in regulatory affairs with responsibilities in pharmaceutical/biotech regulatory affairs. The programme is an opportunity for participants to establish valuable networks with colleagues and teachers from around the world. The master’s programme is designed for combination with a busy job.
The first Master of Pharmaceutical Regulatory Affairs has graduated
Lisbeth Thyregod is Regulatory Affairs Manager at Johnson & Johnson Consumer Nordic . Now she is also the first Master of Pharmaceutical Regulatory Affairs (MPRA) - a part-time study programme offered by the Faculty of Pharmaceutical Sciences in collaboration with Medicademy.
- In May 2005 I attended the first module at Medicademy with the desire to improve my qualification within regulatory affairs and get an overview of regulatory requirements in the pharmaceutical area, says Lisbeth Thyregod and continues:
- In my current job the MPRA programme has helped me a lot, and my overview of the regulatory jungle has helped my company obtain approvals that have been underway for some years.
Read more about Lisbeth's education and master's project in the forthcoming issue of Plexus.
Stine Rasmussen, 18 February 2011.
